Liver failure: Basis of benefit of therapy with the molecular adsorbents recirculating system

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 9, 2003, Pages 1306-1311

  Sen, Sambit ^a   Jalan, Rajiv ^a   Williams, Roger ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Albumin dialysis; Liver failure

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; BRAIN DISEASE; DETOXIFICATION; DEVICE; DIALYSATE; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPERBILIRUBINEMIA; KIDNEY FUNCTION; LIVER FAILURE; MOLECULAR ABSORBENTS RECIRCULATING SYSTEM; REVIEW; SURVIVAL RATE;

EID: 0038044655     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00045-1     Document Type: Review

References (22)

1. Abouna G.M. Cross-circulation between man and baboon in hepatic coma. Lancet. 2:1968;729-730.
2. Arroyo V. Review article: Albumin in the treatment of liver diseases-new features of a classical treatment. Aliment Pharmacology & Therapeutics. 16(Suppl. 5):2002;1-5.
3. Beck R., Bertolino S., Abbot S.E., Aaronson P.I., Smirnov S.V. Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circulation Research. 83:1998;923-931.
4. Bertucci C., Barsotti M.C., Raffaelli A., Salvadori P. Binding properties of human albumin modified by covalent binding of penicillin. Biochimica et Biophysica Acta. 1544:2001;386-392.
5. Cantin A.M., Paquette B., Richter M., Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. American Journal of Respiration and Critical Care Medicine. 162:2000;1539-1546.
6. Evans T.W. Review article: Albumin as a drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacology & Therapeutics. 16(Suppl. 5):2002;6-11.
7. Heemann U., Treichel U., Loock J., Philipp T., Gerken G., Malago M., Klammt S., Loehr M., Liebe S., Mitzner S., Schmidt R., Stange J. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology. 36:2002;949-958.
8. Hughes R., Ton H.Y., Langley P., Davies M., Hanid M.A., Mellon P., Silk D.B., Williams R. Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part II. In vivo evaluation. Artificial Organs. 3:1979;23-26.
9. Jalan R., Sen S., Steiner C., Kapoor D., Alisa A., Williams R. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. Journal of Hepatology. 38:2003;24-31.
10. Mitzner S.R., Klammt S., Peszynski P., Hickstein H., Korten G., Stange J., Schmidt R. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Therapeutics Apheresis. 5:2001;417-422.
11. Mitzner S.R., Stange J., Klammt S., Risler T., Erley C.M., Bader B.D., Berger E.D., Lauchart W., Peszynski P., Freytag J., Hickstein H., Loock J., Lohr J.M., Liebe S., Emmrich J., Korten G., Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transplantation. 6:2000;277-286.
12. Ortega R., Gines P., Uriz J., Cardenas A., Calahorra B., De Las Heras D., Guevara M., Bataller R., Jimenez W., Arroyo V., Rodes J. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study. Hepatology. 36:2002;941-948.
13. Peszynski P., Klammt S., Peters E., Mitzner S., Stange J., Schmidt R. Albumin dialysis: Single pass vs. recirculation (MARS). Liver. 22(Suppl. 2):2002;40-42.
14. Quinlan G.J., Margarson M.P., Mumby S., Evans T.W., Gutteridge J.M. Administration of albumin to patients with sepsis syndrome: A possible beneficial role in plasma thiol repletion. Clinical Science (London). 95:1998;459-465.
15. Sen S., Davies N.A., Mookerjee R.P., Cheshire L., Williams R., Jalan R., Pathophysiological basis of clinical changes in acute-on-chronic liver failure following treatment with MARS: A randomized evaluation. In Proceedings of the fourth international symposium on albumin dialysis in liver disease, Rostock-Warnemunde, September 2002.
16. Sen S., Williams R., Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver. 22(Suppl. 2):2002;5-13.
17. Sen S., Ratnaraj N., Davies N.A., Mookerjee R.P., Cooper C.E., Patsalos P.N., Williams R., Jalan R. Treatment of phenytoin toxicity by the Molecular Adsorbents Recirculating System (MARS). Epilepsia. 44:2003;265-267.
18. Sorkine P., Ben Abraham R., Szold O., Biderman P., Kidron A., Merchav H., Brill S., Oren R. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Critical Care Medicine. 29:2001;1332-1336.
19. Sort P., Navasa M., Arroyo V., Aldeguer X., Planas R., Ruiz-del-Arbol L., Castells L., Vargas V., Soriano G., Guevara M., Gines P., Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. New England Journal of Medicine. 341:1999;403-409.
20. Stange J., Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. International Journal of Artificial Organs. 19:1996;677-691.
21. Stange J., Mitzner S.R., Risler T., Erley C.M., Lauchart W., Goehl H., Klammt S., Peszynski P., Freytag J., Hickstein H., Lohr M., Liebe S., Schareck W., Hopt U.T., Schmidt R. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artificial Organs. 23:1999;319-330.
22. Stange J., Ramlow W., Mitzner S., Schmidt R., Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artificial Organs. 17:1993;809-813.